Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
BMSC-derived extracellular vesicles affect gluconeogenesis and lipogenesis by releasing 5'-tRF-GlyCCC to improve MAFLD insulin sensitivity
Cell Biology and Toxicology
December 2026
Yang C.
Open Access
Mesenchymal stem cells and extracellular vesicles for MAFLD: from biological mechanisms to translational prospects
Stem Cell Research and Therapy
December 2026
Huang Z.
Open Access
Protective Effects of Nanocurcumin and Fenofibrate on Diet-Induced Nonalcoholic Steatohepatitis in Rats: A Study on Modulation of Oxidative Stress
Jundishapur Journal of Natural Pharmaceutical Products
February 2026
Naeeni B.
Open Access
Comparative Therapeutic Effects of LPS-Primed MSC-Derived Exosomes and Saroglitazar in a Wistar Rat Model of Non-Alcoholic Steatohepatitis via AMPK/ACC Signaling Modulation
Hepatitis Monthly
January 2026
Shakerian E.
Open Access
Advancing metabolic dysfunction associated steatotic liver disease (MASLD) Treatment: Exploring novel formulations and therapies
Journal of Drug Delivery Science and Technology
January 2026
Barbhuiya P.A.
Poly(I:C)-Stimulated Exosomes Mitigate Cholesterol-Induced Hepatic Fibrosis by Modulating the TGF-β/Smad3 Signal Transduction Pathway
Hepatitis Monthly
Dec 2025
Asadizadeh S.
Open Access
Stem Cell-Derived Exosomes Significantly Boost Etoposide-Induced Apoptosis in HepG2 Liver Cancer Cells: A Novel Strategy for Enhanced Chemotherapy
Hepatitis Monthly
Dec 2025
Naeeni B.
Open Access
Cell and gene therapeutic approaches in non-alcoholic fatty liver disease
Gene
10 July 2025
Poudineh M.
Induction of Apoptosis in HepG2 Cancer Cells by Mesenchymal Stem Cell-Derived Exosomes via Reactive Oxygen Species Production
Journal of Isfahan Medical School
March 2025
Saki S.
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease
Frontiers in Endocrinology
2025
Qin D.
Open Access
Natural small molecules synergize mesenchymal stem cells for injury repair in vital organs: a comprehensive review
Stem Cell Research and Therapy
December 2024
Qu Y.
Open Access
Anti-fibrotic Potential of WJ-MSC Exosomes in Liver Fibrosis: Mechanistic Insights and Dose-Response Efficacy
Iranian Journal of Pharmaceutical Research
Dec 2024
Khedri A.
Open Access
USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway
Pharmacological Research
November 2024
Wang Y.
Open Access
Three-Dimensional Bioprinting of Tarsal Plates with Adipose-Derived Mesenchymal Stem Cells: Evaluation of Meibomian Gland Reconstruction in a Rat Model
Biomedicines
November 2024
Lee H.
Open Access
Biocompatible Poly(ε-Caprolactone) Nanocapsules Enhance the Bioavailability, Antibacterial, and Immunomodulatory Activities of Curcumin
International Journal of Molecular Sciences
October 2024
D’Angeli F.
Open Access
Unraveling the Exosome-miR-133a Axis: Targeting TGF-β Signaling via WJ-MSC-Derived Exosomes for Anti-Fibrotic Therapy in Liver Fibrosis
Iranian Biomedical Journal
September 2024
Saki S.
Open Access
Regulatory, diagnostic, and therapeutic roles of microRNAs in chronic liver diseases
Acta Gastro Enterologica Belgica
July - September 2024
Kazemzadeh R.
Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease
World Journal of Stem Cells
2024
Jiang Y.
Open Access